Haemonetics rises after all-cash deal to acquire OpSens

Opsens

10/10/2023 16:07

** Shares of Haemonetics Corp  HAE.N  rise 2.2% to $92.74 
    ** The healthcare company will acquire heart
diseases-focused medical device company OpSens Inc  OPS.TO  in
an all-cash transaction 
    ** Haemonetics says it will acquire all outstanding shares
of OpSens for C$2.90 ($2.14) per share representing a fully
diluted equity value of about $253 mln at current exchange rate 
    ** Adds that it plans to finance the acquisition through a
combination of cash and a revolving credit facility
    ** Co expects this transaction to be immediately accretive
to adj earnings per diluted share 
    ** The transaction is expected to close by the end of
January 2024 
    ** Including session moves, stock up 17.9% this year 

    ($1 = 1.3579 Canadian dollars)

 (Reporting by Pratik Jain in Bengaluru)
 ((Pratik.Jain@thomsonreuters.com;))